Skip to content
  • Learn More
  • Publications
  • Team
  • Contact Us
Menu
  • Learn More
  • Publications
  • Team
  • Contact Us

PRISM will be accepting submissions for our next screen May 27 – June 13!

DMSO-soluble small molecules (single agent and combination format) and single agent antibodies, ADCs, and growth-inhibiting cytokines will be accepted for our 930 cancer cell line screen.

Contact us to learn more

Miss our team at AACR 2025? Check out our poster presentations!

Could a drug for arthritis in dogs also fight cancer in people?

PRISM Logo in White

The Broad Institute of MIT and Harvard
75 Ames Street
Cambridge, MA 02142

PRISM@BroadInstitute.org

Join our newsletter to stay up to date with PRISM.

Copyright © 2023. All Rights Reserved.

Conference Posters + Abstracts:
AACR 2025

  • PRISM cancer cell viability profiling enables insights into clinical candidate target selectivity: A case study revealing the most selective PRMT5 inhibitors for cancers with MTAP loss – Abstract | Poster
  • Accelerating the development of biologics: PRISM high throughput screening enables rapid preclinical characterization of antibodies, ADCs and payloads – Abstract | Poster
  • A cellular platform for systematic comparison of RAS inhibitors using PRISM multiplexed screening – Abstract | Poster